Navigation Links
Copan Announces the Appointment of Bob Cooper as Vice President of Business Development in the Pacific Rim
Date:2/16/2009

LIMMERICK, Ireland, Feb. 16 /PRNewswire/ -- Copan Innovation Ltd., whose subsidiary Copan Italia, S.p.A. is the leading manufacturer of collection and transport systems in the world, has named Bob Cooper as its new Vice President of Business Development in the Pacific Rim, as well as appointed Mr. Cooper to the board of directors at Copan Innovation Ltd.

Bob Cooper, who brings a background of twenty five years in senior management positions at several international corporations in healthcare related industries, specifically nine years of experience in high technology laboratory automation, will be responsible for developing and managing a distribution network in the Pacific Rim for Copan's newly launched instrumentation for clinical microbiology. Copan has recently launched a complete line of products under the Copan Automation brand, and Mr. Cooper will lead the expansion in Asia, Australia and New Zealand. His experience in healthcare includes capital equipment, medical devices and software, intellectual property, licensing of technology, development of strategic alliances and international business, and his experience will facilitate Copan's expansion in the rapidly growing economies in the Pacific Rim.

"Bob's diversity of experience in the laboratory automation market and his wealth of direct international business experience will be essential to Copan's rapid market penetration in the clinical microbiology automation market," said Daniele Triva, Copan Innovation Ltd., CEO. "The launch of the new line of Liquid-Based Microbiology products and the WASP [Walk-Away Specimen Processor] are exciting projects for Copan and it solidifies our commitment to innovation in pre-analytics in clinical microbiology," added Mr. Triva.

Bob Cooper is the latest addition to Copan's growing team of professionals committed to the success of Copan's new venture, which in recent months have included the appointment of seasoned Business Development Managers in the US and Europe. Cooper's addition to the Copan leadership team, and the breakthrough technology behind the WASP, provide the ideal composition and opportunity for Copan to help laboratories in different parts of the world achieve efficiencies and productivity in microbiology specimen processing, where full automation had not previously existed.

About the Copan Group

With a reputation for innovation in preanalytics, the Copan Group, comprising of Copan Innovation Ltd., Copan Italia, S.p.A., Copan Diagnostics Inc. and MicroRheologics S.r.l., is the leading manufacturer and provider of collection and transport systems in the world. Copan offers a complete range of microbial sampling products used for traditional culture analysis and for molecular diagnostic assays, as well as producing innovations, like the patented Flocked Swabs, Universal Transport Medium and ESwab. The company manufactures a comprehensive line of laboratory consumables comprising of inoculation loops, needles, spreaders and transfer pipettes. Copan has recently launched WASP: Walk-Away Specimen Processor, a new revolutionary system for automatic planting and streaking of microbiology samples. For more information about Copan, visit www.copaninnovation.com


'/>"/>
SOURCE Copan Innovation Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008
2. Hong Kong Biotech Company, Filligent, Announces CE Certification of Its Revolutionary, Anti-Infective Medical Face Mask, the BioMask
3. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
4. Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
5. Savient Announces Appointment of David Gionco as Chief Financial Officer
6. Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
7. SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS
8. Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009
9. Cord Blood Announces $1 Million Reduction in Long Term Debt
10. BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors
11. XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Miami (PRWEB) , ... February 11, 2016 , ... ... opening of its new stem cell treatment clinic in Quito, Ecuador. The new ... orthopedic and trauma applications to patients from around the world. , The ...
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
(Date:2/10/2016)... plc (NYSE: AGN ) a leading global pharmaceutical ... CEO and President, will be featured as the keynote ... Capital Markets Healthcare Conference on Tuesday, February 23, 2016 ... Hotel in New York, NY . ... accessed on Allergan,s Investor Relations web site at ...
(Date:2/10/2016)... NY (PRWEB) , ... February 10, 2016 , ... LATHAM, ... packages at the SPIE Photonics West conference in San Francisco’s Moscone Center ... 14 in the same venue. , These latest InGaAs PIN diode standard packages ...
Breaking Biology Technology:
(Date:2/1/2016)... 2016  Wocket® smart wallet ( www.wocketwallet.com ) announces the launch of ... Fatone . Las Vegas , where Joey appeared ... Las Vegas , where Joey appeared at the Wocket ... video ad was filmed at the Consumer Electronics Show (CES2016) in ... to meet and greet fans. --> ...
(Date:1/25/2016)... Jan. 25, 2016  Glencoe Software, the world-leading supplier ... publication industries, will provide the data management solution OMERO ... Photo ... Phenotypic analysis measures the characteristics ... allowing comparisons between states such as health and disease, ...
(Date:1/20/2016)... A market that just keeps on growing. Molecular Diagnostics ... genomics knowledge. Learn all about it in this new ... trends are pushing market growth and company valuations. Trends ... pathogen evolution - next generation sequencing - emergence of ... the role of genetic material in Disease and Health ...
Breaking Biology News(10 mins):